Qinhai Ma

InstitutionSouthern Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 1 publications in April 2020 and July 2020 and August 2020 and January 2021 and March 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 13 publications over 6 distinct years, with a maximum of 4 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hua C, Ma Q, Zhu Y, Xia S, Liu Z, Li L, Lu L, Zhong N, Liu S, Yang Z, Jiang S. Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation. Signal Transduct Target Ther. 2021 08 26; 6(1):318. PMID: 34446694.
      Citations: 1     Translation:Humans
    2. Ma Q, Xie Y, Wang Z, Lei B, Chen R, Liu B, Jiang H, Wang Y, Liu Q, Yang Z. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. J Ethnopharmacol. 2021 Oct 28; 279:114367. PMID: 34174375.
      Citations: 1     Fields:    Translation:HumansCells
    3. Zheng B, Yuan M, Ma Q, Wang S, Tan Y, Xu Y, Ye J, Gao Y, Sun X, Yang Z, Xu P, Kong L, Wu X, Xu Q. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues. Int Immunopharmacol. 2021 Jun; 95:107567. PMID: 33756225.
      Citations: 2     Fields:    Translation:HumansCells
    4. Liang T, Qiu J, Niu X, Ma Q, Zhou C, Chen P, Zhang Q, Chen M, Yang Z, Liu S, Li L. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor. Front Pharmacol. 2020; 11:603830. PMID: 33519467.
      Citations: 1     
    5. Ma Q, Li R, Pan W, Huang W, Liu B, Xie Y, Wang Z, Li C, Jiang H, Huang J, Shi Y, Dai J, Zheng K, Li X, Hui M, Fu L, Yang Z. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-?B) signaling pathway. Phytomedicine. 2020 Nov; 78:153296. PMID: 32890913.
      Citations: 15     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    6. Ma Q, Qiu M, Zhou H, Chen J, Yang X, Deng Z, Chen L, Zhou J, Liao Y, Chen Q, Zheng Q, Cai L, Shen L, Yang Z. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Pharmacol Res. 2020 10; 160:105073. PMID: 32653650.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    7. Ma Q, Pan W, Li R, Liu B, Li C, Xie Y, Wang Z, Zhao J, Jiang H, Huang J, Shi Y, Dai J, Zheng K, Li X, Yang Z. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-?B signaling pathway. Pharmacol Res. 2020 08; 158:104850. PMID: 32360580.
      Citations: 30     Fields:    Translation:HumansAnimalsCellsPHPublic Health